Skip to content

PainVision Apparatus for Efficacy Comparison of Treatments for Herpes Zoster Neuralgia

PainVision Apparatus for Efficacy Comparison of Treatments for Herpes Zoster Neuralgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034911
Enrollment
Unknown
Registered
2020-07-24
Start date
2019-05-01
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster Neuralgia

Interventions

Case series:short-term spinal cord stimulation combined with pulsed radiofrequency

Sponsors

First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 50 years old with cervical, thoracic or lumbar herpes zoster neuralgia, with a course of 1-4 months; 2. Mainly persistent pain, VAS >4; 3. Poor drug treatment, or difficult to tolerate side effects; 4. Patients could describe symptoms well and follow the instructions for PainVision; 5. Patients agree to stop using pain medication before VAS and PainVision measurements; 6. Patients accepted short-term spinal cord stimulation or pulsed radiofrequency when necessary

Exclusion criteria

Exclusion criteria: 1. Surgical contraindications such as infection, coagulopathy, severe spinal deformity, severe liver or kidney failure and serious heart or brain diseases; 2. Severe anxiety and depression; 3. SHN has been treated with minimally invasive surgery.

Design outcomes

Primary

MeasureTime frame
Pain Degree;VAS;

Countries

China

Contacts

Public ContactSong Tao

First Affiliated Hospital of China Medical University

752355520@qq.com+86 15998206066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026